Literature DB >> 4135502

Prolonging remission in myeloblastic leukemia by tice-strain bacillus Calmette-Guérin.

W R Vogler, Y K Chan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4135502     DOI： 10.1016/s0140-6736(74)91556-6

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  13 in total

1.  Immunotherapy and chemoimmunotherapy of malignant disease with BCG and nonviable mycobacterial fractions.

Authors:  M A Schwarz; J U Gutterman; E M Hersh; S P Richman; G M Mavligit
Journal:  World J Surg       Date:  1977-09       Impact factor: 3.352

2.  Effects of BCG, Corynebacterium parvum, and methanol-extration residue in the reduction of mortality from Staphylococcus aureus and Candida albicans infections in immunosuppressed mice.

Authors:  N A Sher; S D Chaparas; L E Greenberg; S Bernard
Journal:  Infect Immun       Date:  1975-12       Impact factor: 3.441

3.  A randomized trial of chemoimmunotherapy of acute nonlymphocytic leukemia in adults using a protein-bound polysaccharide preparation.

Authors:  R Ohno; K Yamada; T Masaoka; T Ohshima; I Amaki; Y Hirota; N Horikoshi; A Horiuchi; K Imai; I Kimura
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

Review 4.  Advances in the management of adult acute myelogenous leukaemia.

Authors:  J A Whittaker
Journal:  Br Med J       Date:  1980-10-11

5.  Adjuvant specific immunotherapy in maintenance treatment of adult acute non-lymphocytic leukemia.

Authors:  H Rühl; H H Fülle; K M Koeppen; R Schwerdtfeger
Journal:  Klin Wochenschr       Date:  1981-11-02

6.  Recurrent malignant melanoma: effect of adjuvant immunotherapy on survival.

Authors:  P B McCulloch; P B Dent; M Blajchman; W M Muirhead; R A Price
Journal:  Can Med Assoc J       Date:  1977-07-09       Impact factor: 8.262

7.  Immunotherapy in the treatment of acute myelogenous leukemia (AML): rationale, results and future prospects.

Authors:  D Urbanitz; T Büchner; H Pielken; J van de Loo
Journal:  Klin Wochenschr       Date:  1983-10-03

8.  Immunotherapy of a plasmacytoma with attenuated salmonella.

Authors:  T K Eisenstein; B Bushnell; J J Meissler; N Dalal; R Schafer; H F Havas
Journal:  Med Oncol       Date:  1995-06       Impact factor: 3.064

9.  Granuloma formation in patients receiving BCG immunotherapy.

Authors:  J A Whittaker; D P Bentley; G R Melville-Jones; A J Slater
Journal:  J Clin Pathol       Date:  1976-08       Impact factor: 3.411

10.  Immunotherapy for acute myelogenous leukaemia: a controlled clinical study 2 1/2 years after entry of the last patient.

Authors:  R L Powles; J Russell; T A Lister; T Oliver; J M Whitehouse; J Malpas; B Chapuis; D Crowther; P Alexander
Journal:  Br J Cancer       Date:  1977-03       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.